Divestiture of Preclinical Small Molecule Programs (Details) $ in Thousands		3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	May 01, 2024 ft² extension_option
Disposal Groups, Including Disposal Of Long-Lived Assets [Line Items]
Equity consideration received in the divestiture of small molecule programs (Note 10)		$ 15,000	$ 0
Gain from divestiture of small molecule programs		14,537	$ 0
Venture Backed Private Company ("VBPC")
Disposal Groups, Including Disposal Of Long-Lived Assets [Line Items]
Equity consideration received in the divestiture of small molecule programs (Note 10)	$ 15,000
Noncash or part noncash divestiture, milestone payments, to be received	$ 1,200,000	$ 1,200,000
Future royalties, threshold after first commercial sale	10 years	10 years
Gain from divestiture of small molecule programs		$ 14,500
Subsequent Event
Disposal Groups, Including Disposal Of Long-Lived Assets [Line Items]
Lessor, operating sublease, rentable area | ft²				12,985
Sublease term				10 months
Lessor, operating sublease, number of options to extend | extension_option				2
Sublease renewal option term				6 months